A Tale Of Two Expectations: NDI Notification Estimate And Guidance

Regulatory Burden Notice Prompts Doubt While Hope Endures For Revised Draft

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".